| Literature DB >> 19657323 |
Keizo Kanasaki1, Raghu Kalluri.
Abstract
Preeclampsia is a systemic disease that results from placental defects and occurs in about 5-8% of pregnancies worldwide. Preeclampsia is a disease of many theories, wherein investigators put forward their favorite mechanistic ideas, each with a causal appeal for the pathogenesis of preeclampsia. In reality, the patho-mechanism of preeclampsia remains largely unknown. Preeclampsia, as diagnosed in patients today, is likely a heterogeneous collection of disease entities that share some common features but also show important differences. Therefore, one single mechanism may never be found to explain all the variants of preeclampsia. Current research must focus on evaluating such diverse mechanisms, as well as the possible common effector pathways. Here, we provide a discussion of several possible mechanisms and putative theories proposed for preeclampsia, with particular emphasis on the recent discovery of a new genetic mouse model offering new opportunities to explore experimental therapies.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19657323 PMCID: PMC4313558 DOI: 10.1038/ki.2009.284
Source DB: PubMed Journal: Kidney Int ISSN: 0085-2538 Impact factor: 10.612